SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001169245-20-000059
Filing Date
2020-06-05
Accepted
2020-06-05 18:52:29
Documents
1
Period of Report
2020-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_159139753121334.html 4  
1 FORM 4 wf-form4_159139753121334.xml 4 3992
  Complete submission text file 0001169245-20-000059.txt   5578
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Issuer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 300 ELLIOTT AVE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address
Loewy Caroline M (Reporting) CIK: 0001367451 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38697 | Film No.: 20947724